Enter your login e-mail to the account
Search
- ATRIAL FIBRILLATION IN GENERAL PRACTITIONER‘S PRACTICE AND VALUE OF RAAS INHIBITORS IN PREVENTION AND TREATMENT OF THIS ARRHYTHMIA
MUDr. Peter Jonáš, MUDr. Anton Farkaš
(12/2007, clearly ) - Apixaban has been available for the treatment of venous thromboembolic disease for more than two years
Prof. MUDr. Debora Karetová, CSc., Prof. MUDr. Jan Bultas, CSc.
(1/2018, Drugs & drug classes ) - Antiatherogenic effect and cardiovascular benefit of GLP-1 receptor´s agonists
doc. MUDr. Štefan Farský, CSc., FESC
(4/2022, Drugs & drug classes ) - INTRODUCTION TO THE VASCULAR BRAIN DISEASE ISSUES
h.doc. MUDr. Miroslav Brozman, CSc.
(5/2006, Main topic ) - Cardioembolic stroke
prof. MUDr. Peter Mitro, PhD.
(1/2020, Review articles ) - Criteria for the selection of anticoagulant therapy for atrial fibrillation in selected risk groups of patients
Prof. MUDr. Ján Kmec, PhD., MPH, FESC, MUDr. Martin Kmec
(1/2023, Review articles ) - ATRIAL FIBRILLATION: TO ACCEPT THE ARRHYTHMIA OR TO PUSH FOR SINUS RHYTHM?
MUDr. Peter Hlivák, prof. MUDr. Robert Hatala, CSc.
(9/2006, clearly ) - Current combination of beta-blockers and diuretics in treatment of hypertension
MUDr. Slavomír Šuch
(3/2009, Review articles ) - Anticoagulant therapy in patients with atrial fibrillation
Doc. MUDr. Ján Kmec, PhD., MPH
(2/2017, Review articles ) - Indications for urgent oesophagogastroduodenoscopy and management of these conditions
MUDr. Vladimír Klinovský
(2/2017, Review articles ) - Anticoagulation treatment in praxis of general practitioner for adults
MUDr. Peter Marko, MPH
(2/2011, General Medicine ) - Overview of pharmacotherapy of atrial fibrillation (update for general practitioners)
doc. MUDr. Ján Kmec, PhD.
(5/2012, Review articles ) - Meranie tlaku krvi pri fibrilácii predsiení
doc. MUDr. Štefan Farský, CSc., FESC
(S1/2011, Supplement ) - POSITION OF ANGIOTENSIN 2-RECEPTOR BLOCKERS IN THE TREATMENTS OF ARTERIAL HYPERTENSION AND CURRENT MEDICINE
doc. MUDr. Marian Sninčák, PhD.
(1/2007, Topic ) - Contribution of general practitioner to screening,
treatment
and prevention complication by atrial fibrillation – epidemiological data
from
practice of general practitioner
MUDr. Michaela Macháčová
(6/2017, Original articles & case reports ) - Contemporary antiplatelet treatment in clinical practice
doc. MUDr. Jiří Špác, CSc.
(S3/2010, Supplement ) - PHARMACOLOGICAL TREATMENT OF SUPRAVENTRICULAR ARRHYTHMIAS
MUDr. Ján Kmec, PhD.
(6/2008, Main topic ) - NON-INVASIVE DIAGNOSTICS OF CARDIAC RHYTHM DISTURBANCES
MUDr. Pavel Kmeč
(6/2008, Main topic ) - INVASIVE DIAGNOSTICS AND TREATMENT OF SUPRAVENTRICULAR ARRHYTHMIAS
MUDr. Adrian Bystriansky
(6/2008, Main topic ) - New knowledge on the relationship of tobacco smoking and the risk of atrial fibrillation
prof. MUDr. Ján Murín, CSc., doc. MUDr. Jozef Bulas, CSc., prof. MUDr. Martin Wawruch, PhD., prof. MUDr. Ľudovít Gašpar, CSc.
(3/2020, Review articles ) - Prevention of stroke in atrial fibrillation: current state and trends
doc. MUDr. Marian Sninčák, PhD., MUDr. Kamil Kolesár
(1/2012, Interdisciplinary consilium ) - Warfarin – old friend
MUDr. Vladimír Tuka, Ph.D., MUDr. Tomáš Janota, CSc.
(1/2012, Drugs & drug classes ) - Antikoagulační léčba ve stáří
doc. MUDr. Jiří Špác, CSc.
(3/2018, Review articles ) - TREATMENT OF ARRYTHMIA AND PHARMACOTHERAPY POSSIBILITIES
doc. MUDr. Peter Mitro, PhD.
(11/2007, Topic ) - Pharmacotherapy of stable angina pectoris – current review
MUDr. Anna Vachulová, PhD., MUDr. Mgr. Zuzana Lovásová, MUDr. Martina Kováčová, MUDr. Kristína Letková
(1/2011, Review articles ) - Stroke prevention in cardiologist´s and GP´s hands
MUDr. Roman Margóczy
(6/2019, In short )
- Poruchy srdečního rytmu ve vztahu k neurologickým chorobám
MUDr. Andrea Bártková
(1/2005, Main topic ) - Monitoring of the efficacy of novel oral anticoagulants
MUDr. Aleš Tomek, Mgr. Adriana Ruzsiková, MUDr. Marta Zvarová, doc. MUDr. Robert Mikulík, Ph.D.
(3/2014, Main topic ) - Komorbidita a cievne mozgové príhody
doc. MUDr. Zuzana Gdovinová, CSc.
(5/2005, Main topic ) - Intracerebral hemorrhage
MUDr. Martin Šrámek
(2/2017, Main topic ) - Specifics of cerebrovascular diseases in women
MUDr. Matej Škorvánek, MUDr. Norbert Leško, MUDr. Vladimír Haň
(6/2014, Main topic ) - The first administration of idarucizumab with subsequent intravenous thrombolysis and mechanical thrombectomy in Slovakia (a case report)
MUDr. Oto Petrík, MPH, MUDr. Iuliia Travkina, MUDr. Rastislav Bažík, MUDr. Ivan Vulev, PhD., MPH, FCIRSE, MUDr. Eva Unčovská
(5/2018, Case reports ) - Detection of paroxysmal atrial fibrillation in ischaemic stroke patients
MUDr. Petr Janský
(1/2019, Main topic ) - Recurrent transient ischaemic attack as a manifestation of myocardial infarction
doc. MUDr. Zbyněk Kalita, CSc., MUDr. Jana Veselková, MUDr. Hana Študentová
(2/2009, Case reports ) - Intracerebral hemorrhage and anticoagulation therapy
prof. MUDr. Roman Herzig, Ph.D., FESO
(2/2014, Review articles )
- Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles )
- Cardiovascular diseases and psoriasis
MUDr. Zuzana Baranová, PhD.
(3/2016, Review articles )
- MANAGMENT OF PATIENTS WITH ATRIAL FIBRILLATION
MUDr. Enikő Havránková, MUDr. Emőke Šteňová, PhD.
(2/2008, Review articles )
- New drugs registered in the EU in 2015 (III.)
PharmDr. Peter Stanko, Mgr. Zuzana Černáková
(3/2016, New drugs ) - Clinical evaluation of left atrial appendage occlusion with Amplatzer Amulet in patients with atrial fibrillation
PharmDr. Zuzana Koblišková, MUDr. Silvia Mišíková PhD., PharmDr. Zuzana Haramiová, PhD., doc. PharmDr. Tomáš Tesař PhD., MBA, MPH, MSc (HTA), PharmDr. Igor Zajac
(1-2/2020, Original articles ) - Anticoagulation therapy – what a pharmacist should know
doc. MUDr. Jana Hirmerová, Ph.D.
(2/2021, Current pharmacotherapy )
- Abstrakty
(1/2009, Abstracts ) - Svetový hypertenziologický kongres v Číne aj o novej koncepcii hypertenzie
doc. MUDr. Štefan Farský, CSc., FESC
(2/2010, Events ) - Rivaroxaban – metabolism, pharmacologic properties and drug interactions
Doc. MUDr. Tomáš Kvasnička, CSc.
(1/2019, Main topic ) - Edoxaban – metabolism, pharmacological properties and drug interactions
MUDr. Tomáš Bolek, doc. MUDr. Matej Samoš, PhD., MUDr. Barbora Korpallová, MUDr. Lukáš Urban, Ing. Ingrid Škorňová, PhD.
(1/2019, Main topic ) - Chosen problems in management of DOACs from cardiologist point of view
doc. MUDr. Matej Samoš, PhD., MUDr. Tomáš Bolek, Ing. Ingrid Škorňová, PhD., MUDr. Lucia Stančiaková, PhD., Prof. MUDr. Ján Staško, PhD., prof. MUDr. Marián Mokáň, DrSc., FRCP Edin.
(1/2019, Main topic ) - Apixaban – a new oral anticoagulant
prof. MUDr. Peter Kubisz, DrSc., doc. MUDr. Ján Staško, PhD., mim. prof., MUDr. Zuzana Jedináková
(1/2014, Drugs & drug classes ) - Intracerebral hemorrhage and anticoagulation therapy
prof. MUDr. Roman Herzig, Ph.D., FESO
(2/2014, Main topic ) - Inhibitors of factors XI and XII
doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. František Nehaj, PhD., MBA, MUDr. Juraj Chudej, PhD., MBA, MUDr. Lenka Lisá, PhD., MUDr. Ľudmila Lineková, MUDr. Ivan Kecskés, MBA, Prof. MUDr. Ján Staško, PhD.
(1/2024, Review articles ) - Dabigatran-etexilate (Pradaxa®) in prevention of strokes in patients with atrial fibrillation
MUDr. Petr Janský
(1/2013, Drugs & drug classes ) - Management of selected cardiovascular diseases in older patients with haemophilia A
MUDr. Lucia Stančiaková, PhD., MUDr. Miroslava Dobrotová, PhD., MUDr. Pavol Hollý, PhD., MUDr. Ivana Plameňová, PhD., MUDr. Matej Samoš, PhD., MUDr. Tomáš Bolek, prof. MUDr. Peter Kubisz, DrSc., prof. MUDr. Ján Staško, PhD.
(3-4/2017, Main topic ) - Apixaban has been available for the treatment of venous thromboembolic disease for more than two years
Doc. MUDr. Debora Karetová, CSc., prof. MUDr. Jan Bultas, CSc.
(3-4/2017, Drugs & drug classes ) - Laboratórne monitorovanie liečby novými perorálnymi antikoagulanciami – spoločné odporúčania odborných spoločností
Remková A, Hulíková M, Kubisz P, Šimková I, Kamenský G, Lazúrová I, Payer J, Štvrtinová V, Turčáni P
(S4/2013, Supplement ) - New possibilities in treatment of venous thromboembolism – EINSTEIN clinical program
prof. MUDr. Viera Štvrtinová, PhD.
(4/2011, Drugs & drug classes )
- Glycated hemoglobin hba1c as a predictor of apostoperative complications in cardiac surgery
MUDr. Miroslav Gejguš, MUDr. Martin Ledecký, PhD., MUDr. Tomáš Toporcer, PhD., PhDr. Martin Vaľko, MUDr. Ján Luczy, PhD., MPH, doc. MUDr. Adrián Kolesár, PhD., prof. MUDr. František Sabol, PhD., MPH, MBA
(2/2021, Original articles )